FDA-cleared cuffless blood pressure monitoring for continuous hypertension management
Biobeat manufactures a wireless chest patch that delivers 24-hour continuous blood pressure readings without a traditional cuff, FDA-cleared and clinically validated. The tech stack is healthcare-grade: AWS IoT infrastructure (Lambda, RDS, DynamoDB, SNS/SQS) for real-time data ingestion, paired with React and native Android/Kotlin apps for clinician and patient interfaces. Active pain points around scaling backend data ingestion and system stability suggest the product is seeing clinical adoption volume that's outpacing infrastructure—a common inflection point for medical device platforms moving from pilot to distributed deployment.
Notable leadership hires: Financial Director
Biobeat is a medical device company founded in 2016 and headquartered in Boca Raton, Florida. The core product is a non-invasive, wireless patch that monitors blood pressure continuously over 24 hours, eliminating discomfort and white coat syndrome associated with cuff-based measurement. The platform integrates patient-reported symptoms with objective vital-sign data, enabling clinicians to identify trends and make personalized treatment decisions. Current operations focus on international distributor network expansion and regional growth strategy, with active hiring in Israel signaling expanded engineering and financial operations outside the US.
AWS IoT infrastructure (Lambda, ECS, RDS, DynamoDB, SNS, SQS, CloudWatch), React and native mobile (Android/Kotlin), Docker containerization, and OAuth 2.0 / JWT for authentication.
Boca Raton, Florida. The company was founded in 2016 and is currently expanding hiring into Israel.
Other companies in the same industry, closest in size